DE2012667C3 - 3- (4-substituierte-1-Piperazinyl)-carbonylmethyl-2-benzothiazolinone und ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharamazeutische Präparate - Google Patents

3- (4-substituierte-1-Piperazinyl)-carbonylmethyl-2-benzothiazolinone und ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharamazeutische Präparate

Info

Publication number
DE2012667C3
DE2012667C3 DE19702012667 DE2012667A DE2012667C3 DE 2012667 C3 DE2012667 C3 DE 2012667C3 DE 19702012667 DE19702012667 DE 19702012667 DE 2012667 A DE2012667 A DE 2012667A DE 2012667 C3 DE2012667 C3 DE 2012667C3
Authority
DE
Germany
Prior art keywords
carbonylmethyl
general formula
piperazinyl
chloro
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE19702012667
Other languages
German (de)
English (en)
Other versions
DE2012667B2 (de
DE2012667A1 (de
Inventor
Ikuo Yao Ueda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of DE2012667A1 publication Critical patent/DE2012667A1/de
Publication of DE2012667B2 publication Critical patent/DE2012667B2/de
Application granted granted Critical
Publication of DE2012667C3 publication Critical patent/DE2012667C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE19702012667 1969-03-20 1970-03-17 3- (4-substituierte-1-Piperazinyl)-carbonylmethyl-2-benzothiazolinone und ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharamazeutische Präparate Expired DE2012667C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2144869 1969-03-20

Publications (3)

Publication Number Publication Date
DE2012667A1 DE2012667A1 (de) 1970-10-01
DE2012667B2 DE2012667B2 (de) 1981-02-26
DE2012667C3 true DE2012667C3 (de) 1981-11-26

Family

ID=12055228

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19702012667 Expired DE2012667C3 (de) 1969-03-20 1970-03-17 3- (4-substituierte-1-Piperazinyl)-carbonylmethyl-2-benzothiazolinone und ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharamazeutische Präparate

Country Status (11)

Country Link
AT (1) AT301539B (enExample)
BE (1) BE747274R (enExample)
CH (3) CH554363A (enExample)
DE (1) DE2012667C3 (enExample)
DK (1) DK134023B (enExample)
ES (4) ES377689A1 (enExample)
FI (1) FI52088C (enExample)
NL (1) NL7004067A (enExample)
NO (1) NO128822B (enExample)
SE (1) SE360869B (enExample)
SU (3) SU416947A3 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4382934A (en) 1978-10-10 1983-05-10 Fujisawa Pharmaceutical Co., Ltd. Isatin derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4411900A (en) * 1980-01-03 1983-10-25 Fujisawa Pharmaceutical Co., Ltd. Benzhydrylpiperozinyl thiazole derivatives and pharmaceutical composition comprising the same
FR2637286A1 (fr) * 1988-10-04 1990-04-06 Adir Nouveaux derives benzoxazolinoniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL108409C (enExample) * 1958-10-29

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4382934A (en) 1978-10-10 1983-05-10 Fujisawa Pharmaceutical Co., Ltd. Isatin derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same

Also Published As

Publication number Publication date
NL7004067A (enExample) 1970-09-22
DK134023B (da) 1976-08-30
ES377689A1 (es) 1973-01-01
DK134023C (enExample) 1977-03-21
SE360869B (enExample) 1973-10-08
SU420180A3 (ru) 1974-03-15
BE747274R (fr) 1970-08-17
AT301539B (de) 1972-09-11
FI52088C (fi) 1977-06-10
SU416947A3 (ru) 1974-02-25
CH554364A (de) 1974-09-30
DE2012667B2 (de) 1981-02-26
ES406296A1 (es) 1975-09-16
CH565174A5 (enExample) 1975-08-15
FI52088B (enExample) 1977-02-28
SU400104A3 (enExample) 1973-10-03
NO128822B (enExample) 1974-01-14
CH554363A (de) 1974-09-30
ES406297A1 (es) 1975-09-16
DE2012667A1 (de) 1970-10-01
ES406298A1 (es) 1975-09-16

Similar Documents

Publication Publication Date Title
DE1695556C3 (de) 3-Alkyl-1,2,3,4,4a,9-hexahydropyrazino[1,2-f]morphanthridinderivate
DE69014351T2 (de) Pyridincarbonsäureamid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
DD202152A5 (de) Verfahren zur herstellung von phenylpiperazinderivaten
EP1778691A1 (de) Hydrate und polymorphe des 4-[[(7r)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-4-6-oxo-2-piperidinyl|]amino]-3-methoxy-n-(1-methyl-4-piperidinyl)-benzamid, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE1770571C3 (de) 2-Oxo-3-benzothiazolinacetamid-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2311570C2 (de) 4-Aminochinoline, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
DE3685604T2 (de) 1,7-naphthyridinderivate und diese enthaltende arzneimittel.
DE1643262B2 (de) l-Phenoxy^-hydroxy-S-alklyaminopropane, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CH641159A5 (de) Verfahren zur herstellung von neuen guanidinderivaten.
AT368130B (de) Verfahren zur herstellung von neuen 9-aminoalkyl- fluorenen und von deren salzen
DE2316920B2 (de) Benzo eckige klammer auf d eckige klammer zu eckige klammer auf 1,3 eckige klammer zu dioxolderivate, deren herstellung und diese enthaltende arzneimittel
DE68910211T2 (de) Estramustin-ester.
EP0018360B1 (de) N-(5-Methoxybentofuran-2-ylcarbonyl)-N'-benzylpiperazin und Verfahren zu dessen Herstellung
DE3439450A1 (de) 1,2,4-triazolo-carbamate und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
DE69110217T2 (de) Derivate der Kaffeinsäure und sie enthaltende pharmazeutische Zusammensetzungen.
CH645368A5 (de) 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)benzoesaeure-derivate sowie verfahren zu deren herstellung.
DE1967080C3 (de) t-(3,4-Methylendioxybeiizoyl)-2methyl-5-methoxy-3-indolylessigsäureester, Verfahren zu ihrer Herstellung und Arzneipräparate
DE2412520C2 (de) Tricyclische Verbindungen, Verfahren zu deren Herstellung und diese enthaltende Präparate
DE2847624A1 (de) Arylaether von n-alkyl-piperidinen und deren saeureadditionssalze, verfahren zu ihrer herstellung und ihre verwendung
DE2923817C2 (de) (3-Alkylamino-2-hydroxyproposy)-furan-2-carbonsäureanilide und deren physiologisch verträgliche Säureadditionssalze und Verfahren zu deren Herstellung sowie Arzneimittel mit einem Gehalt dieser Verbindungen
DE2012667B2 (de) carbonylmethyl-2-benzothiazolinone und ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharamazeutische Präparate
DE3004348C2 (enExample)
CH666035A5 (de) 8-alpha-acylaminoergolene.
DE69310186T2 (de) 1,2-dihydro-2-oxo-3-aminochinoxalin derivate, ihre verwendung als heilmittel
DE2029991C3 (de) 2-Hydroxy-5-aminobenzamide, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten

Legal Events

Date Code Title Description
8326 Change of the secondary classification
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee